InsiderDB

USAspending · Contract award

MCK: Department of Veterans Affairs contract award

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL

Follow MCK
First observed
Nov 9, 2026, 11:37 AM EST
Event / period date
Apr 1, 2026
Collected
Nov 9, 2026, 11:37 AM EST

Why this is connected

Legal-name match: MCKESSON CORPORATION is MCKESSON CORP (https://www.sec.gov/Archives/edgar/data/927653/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported contract amount

$1,191,348,080.87

Source last modified: May 29, 2026

Award Amount is total obligations on this award, not a new incremental commitment or contract ceiling.

Source evidence

Read the source excerpt or record
{"internal_id":358827358,"Award ID":"36C24026K1007","Recipient Name":"MCKESSON CORPORATION","Award Amount":1191348080.87,"Description":"EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL","Awarding Agency":"Department of Veterans Affairs","Start Date":"2026-04-01","Last Modified Date":"2026-05-29 14:35:57","generated_internal_id":"CONT_AWD_36C24026K1007_3600_36W79720D0001_3600","Primary Place of Performance":{"location_country_code":"USA","country_name":"UNITED STATES","state_code":"TX","state_name":"Texas","city_name":"IRVING","county_code":"113","county_name":"DALLAS","congressional_code":"33","zip4":"750392402","zip5":"75039"},"awarding_agency_id":561,"agency_slug":"department-of-veterans-affairs"}

Price change after we could observe it

-0.26% MCK

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in MCK

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.